Higher plasma PTX-3 concentrations in patients with end-stage HF were associated with worse outcomes in addition to the increased NT-proBNP levels, lower serum sodium concentration, mean arterial blood pressure, BMI, and ischemic etiology of HF [16]. This evidence concerns the gene NPPB and hydrops fetalis.